CLINICAL SIGNIFICANCE OF NESTIN AND ITS ASSOCIATION WITH SURVIVAL IN NEUROENDOCRINE LUNG TUMOURS

被引:0
|
作者
Brominska, Barbara [1 ]
Gabryel, Piotr [2 ]
Jarmolowska-Jurczyszyn, Donata [3 ]
Janicka-Jedynska, Malgorzata [3 ]
Trojanowski, Maciej [4 ]
Sawicka-Gutaj, Nadia [1 ]
Czepczynski, Rafal [1 ]
Gut, Pawel [1 ]
Brominski, Gabriel [1 ]
Dyszkiewicz, Wojciech [2 ]
Wozniak, Aldona [3 ]
Ruchala, Marek [1 ]
机构
[1] Poznan Univ Med Sci, Dept Endocrinol Metab & Internal Med, Przybyszewskiego 49, PL-60355 Poznan, Poland
[2] Poznan Univ Med Sci, Dept Thorac Surg, Poznan, Poland
[3] Poznan Univ Med Sci, Dept Clin Pathol, Poznan, Poland
[4] Greater Poland Canc Ctr, Dept Epidemiol & Canc Prevent, Poznan, Poland
关键词
neuroendocrine markers; neuroendocrine tumours; pulmonary pathology; HEALTH-ORGANIZATION CLASSIFICATION; INTERMEDIATE-FILAMENT NESTIN; STEM-CELLS; EXPRESSION; CANCER; CARCINOMA; EPIDEMIOLOGY; GRADE;
D O I
10.5114/PJP.2017.73924
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Nestin is considered to be a cancer stem cell marker. Nestin expression in neuroendocrine tumours might be useful to predict prognosis and facilitate treatment planning. 88 patients with neuroendocrine lung tumours operated in the Department of Thoracic Surgery from 2007 to 2015 were included into the study. Immunohistochemical staining for nestin was performed. Clinicopathological and survival data were retrospectively analyzed. Nestin expression was detected in 15 (17%) specimens. Multivariate analysis showed that lymph node metastases (p = 0.0001; hazard ratio (HR) = 3.93; confidence interval (CI) 95%: 1.96-7.87), nestin expression (p = 0.034; HR = 2.30; CI 95%: 1.06-4.99) and patient's age (p = 0.024; HR = 1.04; CI 95%: 1.00-1.09) were independent negative prognostic factors. Nestin expression was significantly higher in large cell neuroendocrine carcinoma when compared with carcinoids (p = 0.001). Collected data support the thesis that nestin can be regarded as a biomarker in patients with neuroendocrine lung tumours.
引用
收藏
页码:291 / 296
页数:4
相关论文
共 50 条
  • [1] Clinical significance of blood chromogranin A measurement in neuroendocrine tumours
    Seregni, E
    Ferrari, L
    Bajetta, E
    Martinetti, A
    Bombardieri, E
    ANNALS OF ONCOLOGY, 2001, 12 : S69 - S72
  • [2] 18F-FDG PET/CT and nestin expression as prognostic tools in pulmonary neuroendocrine tumours
    Brominska, Barbara
    Czepczynski, Rafal
    Gabryel, Piotr
    Jarmolowska-Jurczyszyn, Donata
    Janicka-Jedynska, Malgorzata
    Sawicka-Gutaj, Nadia
    Gut, Pawel
    Brominski, Gabriel
    Dyszkiewicz, Wojciech
    Ruchala, Marek
    NUCLEAR MEDICINE COMMUNICATIONS, 2019, 40 (04) : 353 - 360
  • [3] Survival in Patients with Neuroendocrine Tumours of the Small Intestine: Nomogram Validation and Predictors of Survival
    Levy, Sonja
    van Veenendaal, Linde M.
    Korse, Catharina M.
    Breekveldt, Emilie C. H.
    Verbeek, Wieke H. M.
    Vriens, Menno R.
    Kuhlmann, Koert F. D.
    van den Berg, Jose G.
    Valk, Gerlof D.
    Tesselaar, Margot E. T.
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (08) : 1 - 14
  • [4] Molecular alterations of neuroendocrine tumours of the lung
    Rossi, Giulio
    Bertero, Luca
    Marchio, Caterina
    Papotti, Mauro
    HISTOPATHOLOGY, 2018, 72 (01) : 142 - 152
  • [5] Nomogram for individually predicting overall survival in rectal neuroendocrine tumours
    Feng, Xingyu
    Wei, Gengzhou
    Wang, Wei
    Zhang, Yu
    Zeng, Yujie
    Chen, Minhu
    Chen, Ye
    Chen, Jie
    Zhou, Zhiwei
    Li, Yong
    BMC CANCER, 2020, 20 (01)
  • [6] Neuroendocrine tumours of the urinary system and male genital organs: clinical significance
    Mazzucchelli, Roberta
    Morichetti, Doriana
    Lopez-Beltran, Antonio
    Cheng, Liang
    Scarpelli, Marina
    Kirkali, Ziya
    Montironi, Rodolfo
    BJU INTERNATIONAL, 2009, 103 (11) : 1464 - 1470
  • [7] Nestin expression in high-grade osteosarcomas and its clinical significance
    Zambo, Iva
    Hermanova, Marketa
    Krakorova, Dagmar Adamkova
    Mudry, Peter
    Zitterbart, Karel
    Kyr, Michal
    Vesely, Karel
    Sterba, Jaroslav
    Veselska, Renata
    ONCOLOGY REPORTS, 2012, 27 (05) : 1592 - 1598
  • [8] Clinical implications of lung neuroendocrine neoplasm classification
    Metovic, Jasna
    Barella, Marco
    Harari, Sergio
    Pattini, Linda
    Albini, Adriana
    Sonzogni, Angelica
    Veronesi, Giulia
    Papotti, Mauro
    Pelosi, Giuseppe
    EXPERT REVIEW OF ANTICANCER THERAPY, 2021, 21 (04) : 377 - 387
  • [9] CGH findings in neuroendocrine tumours of the lung
    Johnen, G
    Krismann, M
    Jaworska, M
    Müller, KM
    PATHOLOGE, 2003, 24 (04): : 303 - 307
  • [10] Expression of PIN1 in Gastrointestinal Stromal Tumours and its Clinical Significance
    Jiang, Lixin
    Cao, Mingxiao
    Hu, Jinchen
    Chen, Jian
    ANTICANCER RESEARCH, 2016, 36 (03) : 1275 - 1280